Bifidobacterium longum subsp. infantis (B. infantis) is associated with improved growth, the development of intestinal membrane integrity, and is critical for developing immune function. B. infantis is the predominant intestinal organism found in breast-fed infants. B. infantis M-63 was isolated from a healthy infant and clinically proven to colonize the intestines of infants. B. infantis is the only bacterial species able to take up and metabolize all Human Milk Oligosaccharides (HMOs) which allows B. infantis to outcompete other bacterial species. Jarro-Dophilus® Infant is formulated with Medium Chain Triglycerides (MCTs), which are naturally present in breast milk and are more easily absorbed by the newborn's immature digestive system. The Developing Intestinal Microflora of Newborns is up to 90% B. Infantis.
Package Size: 15 ml
Serving Size: 0,5 ml
Servings Per Container: 30
| Supplemental Information | Amount Per Serving | % Daily Value |
| Bifidobacterium longum subsp. infantis M-63 | 1 Billion Viable Cells (minimum) | * |
* Daily Value not established.
Medium chain triglycerides, tapioca starch, calcium phosphate, vitamin E (d-alpha tocopherol from sunflower oil; added to maintain freshness) and citric acid.
For newborns to infants up to 6 months old, add 10 drops, once daily, to foods, lukewarm milk, or an infant formula. Or use as directed by your qualified healthcare professional. Shake bottle well before each use.
The product cannot be used as a substitute (substitute) for a varied diet. A balanced diet and a right lifestyle are important for the functioning of the human body. Do not exceed the recommended maximum daily dose. Store in a cool, dry place after opening.
